Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma

The treatment of metastatic renal cell carcinoma (RCC) and urothelial carcinoma (UC) remains a major challenge. Past research has implicated the immune system in tumor surveillance of both malignancies, leading to the application of immunotherapy agents for both cancers. Among them, the most promisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Zhiying, Wang, Andrew Z., George, Daniel J., Zhang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730869/
https://www.ncbi.nlm.nih.gov/pubmed/29264195
http://dx.doi.org/10.1016/j.ajur.2016.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730869/
https://www.ncbi.nlm.nih.gov/pubmed/29264195
http://dx.doi.org/10.1016/j.ajur.2016.08.013

Ejemplares similares